Developing a COVID-19 Mortality Prediction (CoMPred) Indicator for ICU Diabetic Patients Treated with Tocilizumab in Saudi Arabia: A Proof-of-Concept Study

Since the beginning of the COVID-19 pandemic, efforts have been made to underline its discourse and identify factors contributing to its severe forms. Clinically, many physicians depended on subjective criteria to determine its severe forms, which varied significantly between practices. However, the...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Anwar A. Sayed, Omar M. Al Nozha
Formaat: Artikel
Taal:English
Gepubliceerd in: MDPI AG 2023-09-01
Reeks:Biomedicines
Onderwerpen:
Online toegang:https://www.mdpi.com/2227-9059/11/10/2649